-
Agnello V, Abel G, Elfahal M. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor[J]. Proc Natl Acad Sci USA, 1999, 96(): 12766-12771. doi: 10.1073/pnas.96.22.12766
-
Arduino P G, Porter S R. Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features[J]. J Oral Pathol Med, 2008, 37(): 107-121.
-
Atanasiu D, Whitbeck J C, de Leon MP. Bimolecular complementation defines functional regions of HSV gB that are involved with gH/gL as necessary steps leading to cell fusion[J]. J Virol, 2010, 84(): 3825-3834. doi: 10.1128/JVI.02687-09
-
Banerjee M, Khayat R, Walukiewicz H E. Dissecting the functional domains of a nonenveloped virus membrane penetration peptide[J]. J Virol, 2009, 83(): 6929-6933. doi: 10.1128/JVI.02299-08
-
Barth H, Schafer C, Adah M I. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate[J]. J Biol Chem, 2003, 278(): 41003-41012. doi: 10.1074/jbc.M302267200
-
Bartosch B, Cosset F L. Cell entry of hepatitis C virus[J]. Virology, 2006, 348(): 1-12. doi: 10.1016/j.virol.2005.12.027
-
Basu A, Kanda T, Beyene A. Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells[J]. J Virol, 2007, 81(): 3933-3941. doi: 10.1128/JVI.02622-06
-
Bender F C, Whitbeck J C, Lou H. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry[J]. J Virol, 2005, 79(): 11588-11597. doi: 10.1128/JVI.79.18.11588-11597.2005
-
Bertaux C, Dragic T. Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry[J]. J Virol, 2006, 80(): 4940-4948. doi: 10.1128/JVI.80.10.4940-4948.2006
-
Bevilacqua F, Marcello A, Toni M. Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient[J]. J Acquir Immune Defic Syndr, 1991, 4(): 967-969.
-
Brandenburg B, Lee L Y, Lakadamyali M. Imaging poliovirus entry in live cells[J]. PLoS Biol, 2007, 5(): e183-. doi: 10.1371/journal.pbio.0050183
-
Budkowska A. Mechanism of cell infection with hepatitis C virus (HCV)-a new paradigm in virus-cell interaction[J]. Pol J Microbiol, 2009, 58(): 93-98.
-
Burlone M E, Budkowska A. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors[J]. J Gen Virol, 2009, 90(): 1055-1070. doi: 10.1099/vir.0.008300-0
-
Campadelli-Fiume G, Amasio M, Avitabile E. The multipartite system that mediates entry of herpes simplex virus into the cell[J]. Rev Med Virol, 2007, 17(): 313-326. doi: 10.1002/(ISSN)1099-1654
-
Chandran K, Farsetta D L, Nibert M L. Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption[J]. J Virol, 2002, 76(): 9920-9933. doi: 10.1128/JVI.76.19.9920-9933.2002
-
Codran A, Royer C, Jaeck D. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis[J]. J Gen Virol, 2006, 87(): 2583-2593. doi: 10.1099/vir.0.81710-0
-
Cole N L, Grose C. Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus[J]. Rev Med Virol, 2003, 13(): 207-222. doi: 10.1002/(ISSN)1099-1654
-
De Clercq E. Antiviral drugs in current clinical use[J]. J Clin Virol, 2004, 30(): 115-133. doi: 10.1016/j.jcv.2004.02.009
-
Dicker I B, Blasecki J W, Seetharam S. Herpes simplex type1:lacZ recombinant viruses. Ⅱ. Microtiter plate-based colorimetric assays for the discovery of new antiherpes agents and the points at which such agents disrupt the viral replication cycle[J]. Antiviral Res, 1995, 28(): 213-224. doi: 10.1016/0166-3542(95)00049-R
-
Dreux M, Dao Thi V L, Fresquet J. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra-and extra-cellular domains[J]. PLoS Pathog, 2009, 5(): e1000310-. doi: 10.1371/journal.ppat.1000310
-
Duan R, de Vries R D, Osterhaus A D. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis[J]. J Infect Dis, 2008, 198(): 659-663. doi: 10.1086/592362
-
Dubuisson J, Helle F, Cocquerel L. Early steps of the hepatitis C virus life cycle[J]. Cell Microbiol, 2008, 10(): 821-827. doi: 10.1111/j.1462-5822.2007.01107.x
-
Falanga A, Cantisani M, Pedone C. Membrane fusion and fission: enveloped viruses[J]. Protein Pept Lett, 2009, 16(): 751-759. doi: 10.2174/092986609788681760
-
Falconer M M, Gilbert J M, Roper A M. Rotavirus-induced fusion from without in tissue culture cells[J]. J Virol, 1995, 69(): 5582-5591.
-
Feng Z H, Wang Q C, Nie Q H. DC-SIGN: binding receptor for HCV?[J]. World J Gastroenterol, 2004, (10): 925-929.
-
Field H, McMillan A, Darby G. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs[J]. J Infect Dis, 1981, 143(): 281-285. doi: 10.1093/infdis/143.2.281
-
Garner J A. Herpes simplex virion entry into and intracellular transport within mammalian cells[J]. Adv Drug Deliv Rev, 2003, 55(): 1497-1513. doi: 10.1016/j.addr.2003.07.006
-
Ghukasyan V, Hsu Y Y, Kung S H. Application of fluorescence resonance energy transfer resolved by fluorescence lifetime imaging microscopy for the detection of enterovirus 71 infection in cells[J]. J Biomed Opt, 2007, 12(): 1-8.
-
Grondin B, DeLuca N. Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA[J]. J Virol, 2000, 74(): 11504-11510. doi: 10.1128/JVI.74.24.11504-11510.2000
-
Heo H T. A potential role of the heparan sulfate in the hepatitis C virus attachment[J]. Acta Virol, 2008, 52(): 7-15.
-
Han Q, Xu C, Wu C. Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus[J]. Virus Res, 2009, 145(): 63-73. doi: 10.1016/j.virusres.2009.06.005
-
Hannah B P, Cairns T M, Bender F C. Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops[J]. J Virol, 2009, 83(): 6825-6836. doi: 10.1128/JVI.00301-09
-
Heldwein E E, Krummenacher C. Entry of herpesviruses into mammalian cells[J]. Cell Mol Life Sci, 2008, 65(): 1653-1668. doi: 10.1007/s00018-008-7570-z
-
Helle F, Dubuisson J. Hepatitis C virus entry into host cells[J]. Cell Mol Life Sci, 2008, 65(): 100-112. doi: 10.1007/s00018-007-7291-8
-
Hsu M, Zhang J, Flint M. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles[J]. Proc Natl Acad Sci USA, 2003, 100(): 7271-7276. doi: 10.1073/pnas.0832180100
-
Iro M, Witteveldt J, Angus A G. A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication[J]. Antiviral Res, 2009, 83(): 148-155. doi: 10.1016/j.antiviral.2009.04.007
-
Kalia M, Jameel S. Virus entry paradigms[J]. Amino Acids, 2009, (): -. doi: 10.1007/s00726-009-0363-3
-
Koutsoudakis G, Kaul A, Steinmann E. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses[J]. J Virol, 2006, 80(): 5308-5320. doi: 10.1128/JVI.02460-05
-
Laquerre S, Argnani R, Anderson D B. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread[J]. J Virol, 1998, 72(): 6119-6130.
-
Lavanchy D. The global burden of hepatitis C[J]. Liver Int, 2009, 29 Suppl 1(): 74-81.
-
Lavillette D, Bartosch B, Nourrisson D. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes[J]. J Biol Chem, 2006, 281(): 3909-3917. doi: 10.1074/jbc.M509747200
-
Lee J C, Shih Y F, Hsu S P. Development of a cell-based assay for monitoring specific hepatitis C virus NS3/4A protease activity in mammalian cells[J]. Anal Biochem, 2003, 316(): 162-170. doi: 10.1016/S0003-2697(03)00053-8
-
Lee J C, Yu M C, Lien T W. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors[J]. Assay Drug Dev Technol, 2005, 3(): 385-392. doi: 10.1089/adt.2005.3.385
-
Leung W C. Cooperation between herpes simplex virus specific alpha protein and host cell RNA polymerase Ⅱ in the transcription of viral deoxypyrimidine kinase[J]. Can J Microbiol, 1980, 26(): 401-404. doi: 10.1139/m80-066
-
Liu Y X, Xie J J, He Y X. [Study of the clinical and laboratory features of hand-foot-mouth disease][J]. Chinese J Exp Clin Virol, 2008, 22(): 475-477.
-
Lozach P Y, Amara A, Bartosch B. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles[J]. J Biol Chem, 2004, 279(): 32035-45. doi: 10.1074/jbc.M402296200
-
Ludwig I S, Lekkerkerker A N, Depla E. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation[J]. J Virol, 2004, 78(): 8322-8332. doi: 10.1128/JVI.78.15.8322-8332.2004
-
Madan R P, Mesquita P M, Cheshenko N. Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections[J]. J Virol, 2007, 81(): 7636-7646. doi: 10.1128/JVI.02851-06
-
Mann A M, Rusert P, Berlinger L. HIV sensitivity to neutralization is determined by target and virus producer cell properties[J]. AIDS, 2009, 23(): 1659-1667. doi: 10.1097/QAD.0b013e32832e9408
-
Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs[J]. J Clin Virol, 2003, 26(): 29-37. doi: 10.1016/S1386-6532(02)00263-9
-
Morikawa K, Zhao Z, Date T. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles[J]. J Med Virol, 2007, 79(): 714-723. doi: 10.1002/(ISSN)1096-9071
-
Mudhakir D, Harashima H. Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus[J]. AAPS J, 2009, 11(): 65-77. doi: 10.1208/s12248-009-9080-9
-
Netski D M, Mosbruger T, Depla E. Humoral immune response in acute hepatitis C virus infection[J]. Clin Infect Dis, 2005, 41(): 667-675. doi: 10.1086/432478
-
Nishimura Y, Shimojima M, Tano Y. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71[J]. Nat Med, 2009, 15(): 794-797. doi: 10.1038/nm.1961
-
O'Donnell C D, Tiwari V, Oh M J. A role for heparan sulfate 3-O-sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread[J]. Virology, 2006, 346(): 452-459. doi: 10.1016/j.virol.2005.11.003
-
Ortner B, Huang C W, Schmid D. Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes[J]. J Med Virol, 2009, 81(): 317-324. doi: 10.1002/jmv.v81:2
-
Owsianka A M, Timms J M, Tarr A W. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding[J]. J Virol, 2006, 80(): 8695-704. doi: 10.1128/JVI.00271-06
-
Patel K P, Bergelson J M. Receptors identified for hand, foot and mouth virus[J]. Nat Med, 2009, 15(): 728-729. doi: 10.1038/nm0709-728
-
Pietschmann T, Kaul A, Koutsoudakis G. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras[J]. Proc Natl Acad Sci USA, 2006, 103(): 7408-7413. doi: 10.1073/pnas.0504877103
-
Ploss A, Evans M J, Gaysinskaya V A. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells[J]. Nature, 2009, 457(): 882-886. doi: 10.1038/nature07684
-
Popescu C I, Dubuisson J. Role of lipid metabolism in hepatitis C virus assembly and entry[J]. Biol Cell, , 102(): 63-74. doi: 10.1042/BC20090125
-
Rajcani J, Vojvodova A. The role of herpes simplex virus glycoproteins in the virus replication cycle[J]. Acta Virol, 1998, 42(): 103-118.
-
Ranganathan S, Singh S, Poh C L. The hand, foot and mouth disease virus capsid: sequence analysis and prediction of antigenic sites from homology modelling[J]. Appl Bioinformatics, 2002, 1(): 43-52.
-
Reske A, Pollara G, Krummenacher C. Understanding HSV-1 entry glycoproteins[J]. Rev Med Virol, 2007, 17(): 205-215. doi: 10.1002/(ISSN)1099-1654
-
Schinazi R F, Nahmias A J. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds[J]. Am J Med, 1982, 73(): 40-48. doi: 10.1016/0002-9343(82)90061-4
-
Schwarz A K, Grove J, Hu K. Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization[J]. J Virol, 2009, 83(): 12407-12414. doi: 10.1128/JVI.01552-09
-
Smith J S, Robinson N J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review[J]. J Infect Dis, 2002, 186 Suppl 1(): S3-28.
-
Spear PG. Herpes simplex virus: receptors and ligands for cell entry[J]. Cell Microbiol, 2004, 6(): 401-410. doi: 10.1111/cmi.2004.6.issue-5
-
Stranska R, Schuurman R, Scholl D R. ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing[J]. Antimicrob Agents Chemother, 2004, 48(): 2331-2333. doi: 10.1128/AAC.48.6.2331-2333.2004
-
Tanaka M, Kodaira H, Nishiyama Y. Construction of recombinant herpes simplex virus type Ⅰ expressing green fluorescent protein without loss of any viral genes[J]. Microbes Infect, 2004, 6(): 485-493. doi: 10.1016/j.micinf.2004.01.011
-
Tani H, Komoda Y, Matsuo E. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins[J]. J Virol, 2007, 81(): 8601-8612. doi: 10.1128/JVI.00608-07
-
Taylor T J, Knipe D M. The use of green fluorescent fusion proteins to monitor herpes simplex virus replication[J]. Methods Mol Biol, 2009, 515(): 239-248. doi: 10.1007/978-1-59745-559-6
-
Trybala E, Liljeqvist J A, Svennerholm B. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate[J]. J Virol, 2000, 74(): 9106-9114. doi: 10.1128/JVI.74.19.9106-9114.2000
-
Tscherne D M, Jones C T, Evans M J. Time-and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry[J]. J Virol, 2006, 80(): 1734-1741. doi: 10.1128/JVI.80.4.1734-1741.2006
-
Wang Q C, Feng Z H, Nie Q H. DC-SIGN: binding receptors for hepatitis C virus[J]. Chin Med J (Engl), 2004, 117(): 1395-1400.
-
Wang S M, Ho T S, Shen C F. Enterovirus 71, one virus and many stories[J]. Pediatr Neonatol, 2008, 49(): 113-115. doi: 10.1016/S1875-9572(08)60024-8
-
Wang Y C, Kao C L, Liu W T. A cell line that secretes inducibly a reporter protein for monitoring herpes simplex virus infection and drug susceptibility[J]. J Med Virol, 2002, 68(): 599-605. doi: 10.1002/(ISSN)1096-9071
-
Whidby J, Mateu G, Scarborough H. Blocking hepatitis C virus infection with recombinant form of envelope protein 2 ectodomain[J]. J Virol, 2009, 83(): 11078-11089. doi: 10.1128/JVI.00800-09
-
Wright C C, Wisner T W, Hannah B P. Fusion between perinuclear virions and the outer nuclear membrane requires the fusogenic activity of herpes simplex virus gB[J]. J Virol, 2009, 83(): 11847-11856. doi: 10.1128/JVI.01397-09
-
Wymer J P, Chung T D, Chang Y N. Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2[J]. J Virol, 1989, 63(): 2773-2784.
-
Yamayoshi S, Yamashita Y, Li J. Scavenger receptor B2 is a cellular receptor for enterovirus 71[J]. Nat Med, 2009, 15(): 798-801. doi: 10.1038/nm.1992
-
Yang B, Chuang H, Yang K D. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells[J]. Virol J, 2009, 6(): 141-. doi: 10.1186/1743-422X-6-141
-
Zahn A, Allain J P. Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography[J]. J Gen Virol, 2005, 86(): 677-685. doi: 10.1099/vir.0.80614-0
-
Zeisel M B, Barth H, Schuster C. Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy[J]. Front Biosci, 2009, 14(): 3274-3285.
-
Zeisel M B, Baumert T F. HCV entry and neutralizing antibodies: lessons from viral variants[J]. Future Microbiol, 2009, 4(): 511-517. doi: 10.2217/fmb.09.34
-
Ziegler S, Kronenberger B, Albrecht B A. Development and evaluation of a FACS-based medium-throughput assay for HCV entry inhibitors[J]. J Biomol Screen, 2009, 14(): 620-626. doi: 10.1177/1087057109337161